Following its launch last November, I spent several weeks testing Withings’ BeamO, a three-in-one, FDA-cleared device that functions as a stethoscope, an electrocardiogram and a thermometer. One of my takeaways was that while the device is great for measuring your temperature and listening to your heart and lungs, these readings require a doctor for interpretation. But that will soon change.
On Friday, at IFA 2026, Withings announced StethO Sense, a service that will be available to Withings+ users starting Oct. 1. It uses third-party AI analysis software to analyze BeamO’s heart and lung recordings. According to a statement, it uses eMurmur…
Read the full article at CNET.COM
